.

Make Better Decisions

  • Analyze global market entry opportunities
  • Identify first generic entrants
  • Drug patents in 130+ countries

► See Plans & Pricing

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving 500+ biopharmaceutical companies globally:

Cipla
Chinese Patent Office
Cerilliant
McKinsey
QuintilesIMS
Deloitte
US Army
Julphar
Healthtrust
Covington

Generated: September 20, 2017

DrugPatentWatch Database Preview

Watson Labs Teva Company Profile

« Back to Dashboard

What is the competitive landscape for WATSON LABS TEVA, and what generic and branded alternatives to WATSON LABS TEVA drugs are available?

WATSON LABS TEVA has fifty-two approved drugs.

There is one tentative approval on WATSON LABS TEVA drugs.

Summary for Applicant: Watson Labs Teva

Patents:0
Tradenames:45
Ingredients:42
NDAs:52
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Watson Labs Teva
LEVOFLOXACIN
levofloxacin
SOLUTION/DROPS;OPHTHALMIC076826-001Feb 10, 2011ATRXNoNo► Subscribe► Subscribe► Subscribe
Watson Labs Teva
VALSARTAN AND HYDROCHLOROTHIAZIDE
hydrochlorothiazide; valsartan
TABLET;ORAL091519-005Mar 21, 2013ABRXNoNo► Subscribe► Subscribe► Subscribe
Watson Labs Teva
ACETOHEXAMIDE
acetohexamide
TABLET;ORAL071893-001Nov 25, 1987DISCNNoNo► Subscribe► Subscribe► Subscribe
Watson Labs Teva
VALSARTAN AND HYDROCHLOROTHIAZIDE
hydrochlorothiazide; valsartan
TABLET;ORAL091519-002Mar 21, 2013ABRXNoNo► Subscribe► Subscribe► Subscribe
Watson Labs Teva
SERTRALINE HYDROCHLORIDE
sertraline hydrochloride
TABLET;ORAL077663-001Feb 6, 2007DISCNNoNo► Subscribe► Subscribe► Subscribe
Watson Labs Teva
EZETIMIBE AND ATORVASTATIN CALCIUM
atorvastatin calcium; ezetimibe
TABLET;ORAL206084-001Apr 26, 2017RXNoNo► Subscribe► Subscribe► Subscribe
Watson Labs Teva
DICLOFENAC POTASSIUM
diclofenac potassium
TABLET;ORAL075152-001Nov 27, 1998DISCNNoNo► Subscribe► Subscribe► Subscribe
Watson Labs Teva
SIMVASTATIN
simvastatin
TABLET;ORAL076685-002Dec 20, 2006ABRXNoNo► Subscribe► Subscribe► Subscribe
Watson Labs Teva
DISULFIRAM
disulfiram
TABLET;ORAL086890-001Approved Prior to Jan 1, 1982DISCNNoNo► Subscribe► Subscribe► Subscribe
Watson Labs Teva
EZETIMIBE AND ATORVASTATIN CALCIUM
atorvastatin calcium; ezetimibe
TABLET;ORAL206084-003Apr 26, 2017RXNoNo► Subscribe► Subscribe► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Similar Applicant Names

Individual applicants are sometimes listed under multiple names.
Here is a list of applicants with similar names.

« Back to Dashboard

For more information try a trial or see the database preview and plans and pricing

Serving 500+ biopharmaceutical companies globally:

McKinsey
Merck
Cipla
Chubb
UBS
Johnson and Johnson
Boehringer Ingelheim
Colorcon
US Army
Covington

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted Heap | Mobile and Web Analytics
Privacy and Cookies
Terms & Conditions

Follow DrugPatentWatch:



Google
Twitter
Google Plus
botpot